Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion type Assertion NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_head.
- NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion description "[Anti-Fas monoclonal antibody (mAb) was added to RA synoviocytes after treatment with tumor necrosis factor alpha (TNFalpha) or basic fibroblast growth factor (bFGF) for 5 days.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_provenance.
- NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion evidence source_evidence_literature NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_provenance.
- NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion SIO_000772 10817565 NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_provenance.
- NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion wasDerivedFrom befree-2016 NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_provenance.
- NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_assertion wasGeneratedBy ECO_0000203 NP284387.RANSJD6RB7dM5RmAkmm7YNaaI64QHk87-dBLrQy4uOCKg130_provenance.